Viread Tablet, Coated
Product Images NDC 61958-0406

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Viread (NDC 61958-0406). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Viread 01)

Chemical structure of Tenofovir Disoproxil Fumarate, the active ingredient in Viread. The diagram shows the molecular components and bonds characteristic of Tenofovir Disoproxil Fumarate.*

FDA Label Image

Figure A (Viread 02)

An illustration of a dosing spoon with marked fractional measurements for liquid medication, designed for oral administration. The spoon is transparent, showing volume gradations for accurate dosage.*

FDA Label Image

Figure B (Viread 03)

An instructional illustration showing a hand squeezing powder from a small packet onto a spoon. This image likely relates to the oral powder dosage form of Viread (TENOFOVIR DISOPROXIL FUMARATE), guiding the preparation or administration process.*

FDA Label Image

Figure C (Viread 04)

An instructional diagram showing a beaker with a liquid filled to the halfway mark labeled '1/2 line,' illustrating a measurement reference point for liquid volume.*

FDA Label Image

Prinicpal Display Panel (300 mg Bottle Label)

Label for Viread (tenofovir disoproxil fumarate) tablets, 150 mg strength. The label indicates a package size of 30 tablets, with storage instructions to keep at 25°C (77°F) and keep the container tightly closed. Manufactured for Gilead Sciences, Inc. in Canada.*

FDA Label Image

Prinicpal Display Panel (150 mg Bottle Label)

Viread 200 mg tablets label showing the active ingredient tenofovir disoproxil fumarate. The label states each tablet contains 200 mg tenofovir disoproxil fumarate, equivalent to 163 mg tenofovir disoproxil. The package contains 30 tablets. Manufactured for Gilead Sciences, Inc., with storage instructions at 25°C (77°F). Made in Canada.*

FDA Label Image

Prinicpal Display Panel (200 mg Bottle Label)

Viread (tenofovir disoproxil fumarate) tablets 250 mg label showing a package of 30 tablets. The label is for oral tablets containing 250 mg of tenofovir disoproxil fumarate, equivalent to 204 mg tenofovir disoproxil, manufactured for Gilead Sciences, Inc. Storage and handling instructions are included, along with an Rx only designation.*

FDA Label Image

Prinicpal Display Panel (250 mg Bottle Label)

Label for Viread (tenofovir disoproxil fumarate) tablets, 300 mg strength, containing 30 tablets. The label states the product is manufactured for Gilead Sciences, Inc., and instructs storage at 25 °C (77 °F) with dispensing in the original container. The label includes the NDC 61958-0401-1 and states Rx only.*

FDA Label Image

Prinicpal Display Panel (60 g Bottle Carton)

Label for Viread (tenofovir disoproxil fumarate) Oral Powder, 40 mg per scoop, containing 60 g per bottle. The label includes dosing instructions, storage conditions, and manufacturer information. Manufactured by Adare Pharmaceuticals, Inc. for Gilead Sciences, Inc. The label also indicates the product is prescription only (Rx).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.